0001062993-22-020014.txt : 20220928 0001062993-22-020014.hdr.sgml : 20220928 20220928171821 ACCESSION NUMBER: 0001062993-22-020014 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20220928 DATE AS OF CHANGE: 20220928 EFFECTIVENESS DATE: 20220928 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Awakn Life Sciences Corp. CENTRAL INDEX KEY: 0001948724 IRS NUMBER: 000000000 STATE OF INCORPORATION: A6 FISCAL YEAR END: 0131 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-460183 FILM NUMBER: 221276987 BUSINESS ADDRESS: STREET 1: 301-217 QUEEN ST WEST CITY: TORONTO STATE: A6 ZIP: M5V 0R2 BUSINESS PHONE: 416-907-5644 MAIL ADDRESS: STREET 1: 301-217 QUEEN ST WEST CITY: TORONTO STATE: A6 ZIP: M5V 0R2 D 1 primary_doc.xml X0708 D LIVE 0001948724 Awakn Life Sciences Corp. 301-217 QUEEN ST WEST TORONTO A6 ONTARIO, CANADA M5V 0R2 212-896-1254 ONTARIO, CANADA 1169082 BC Ltd. None Corporation true 2018 Jonathan Held 301-217 Queen St W Toronto A6 ONTARIO, CANADA M5V 0R2 Executive Officer Director Anthony Tennyson 301-214 Queen Street West Toronto A6 ONTARIO, CANADA M5V 0R2 Executive Officer Director Benjamin Sessa 301-214 Queen Street West Toronto A6 ONTARIO, CANADA M5V 0R2 Executive Officer Director James Collins 301-214 Queen Street West Toronto A6 ONTARIO, CANADA M5V 0R2 Executive Officer Shaun McNulty 301-214 Queen Street West Toronto A6 ONTARIO, CANADA M5V 0R2 Executive Officer George Scorsis 301-214 Queen Street West Toronto A6 ONTARIO, CANADA M5V 0R2 Director Other Decline to Disclose 06b false 2022-09-14 false true true true true Each Unit consists of 1 cm sh & 1 cm sh purchase wrt. Each wrt entitles the holder to purchase 1 cm sh at a price of CDN$0.68 for a period of 2 years following the closing date. true 0 284621 130152 154469 "Total Remaining to be Sold" is the aggregate purchase price of shares underlying warrants sold in this offering. U.S. dollar amounts are based on the Bank of Canada exchange rate 0.7595 reported on September 14, 2022. false 4 0 0 0 false Awakn Life Sciences Corp. /s/ Jonathan Held Jonathan Held CFO 2022-09-28